StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$39.43−1.27 (-3.12%)

Close on Nov 18, 2026Market cap $176.06BP/E 11.6Yield –

Novo Nordisk A S market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Novo Nordisk A S's market cap was $182.60B on Nov 11, 2026, against $219.16B a year earlier. Over the last 5 years it ranged from $163.32B to $636.33B, with a median of $306.52B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$182.60B-19.2%
2025Dec 31, 2025$225.96B-41.1%
2024Dec 31, 2024$383.48B-17.6%
2023Dec 29, 2023$465.53B+48.9%
2022Dec 30, 2022$312.64B+18.8%
2021Dec 31, 2021$263.20B+57.0%
2020Dec 31, 2020$167.64B+19.5%
2019Dec 31, 2019$140.32B+22.9%
2018Dec 31, 2018$114.17B-16.1%
2017Dec 29, 2017$136.04B+47.2%
2016Dec 30, 2016$92.44B–

More Novo Nordisk A S figures

See a number that looks wrong?